Investigational Site Number : 3920017

Chuo-ku, Tokyo 104-0031

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma — Completed